Moreover, the long-term treatment (4 days) of PC-3 cells with EA and OeB resulted in up-regulation of neutral endopeptidase (NEP)-metallopeptidase, whose levels decreased in an early premalignant phase of prostate cancer and stromal benign prostate hyperplasia (BPH) [90]. This evidence concerns the gene MME and prostate cancer.